Dallas, TX, United States of America

Dennis McGarry

This inventor holds 1 USPTO granted patent. Top assignees: Betagene, Inc., The University of Texas System. Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dennis McGarry: Innovator in Protein Expression Technology

Introduction

Dennis McGarry is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of biotechnology, particularly in the area of protein expression. His innovative work has implications for both research and therapeutic applications.

Latest Patents

Dennis McGarry holds a patent for the recombinant expression of proteins from secretory cell lines. This invention provides methods for the production of heterologous polypeptides, such as amylin, using recombinantly engineered cell lines. The patent also describes methods for engineering cells for high-level expression, large-scale heterologous protein production, and treatment of diseases in vivo using viral delivery systems and recombinant cell lines. Additionally, it includes methods for isolating novel amylin receptors.

Career Highlights

Throughout his career, Dennis has worked with esteemed organizations, including the University of Texas System and Betagene, Inc. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Dennis has collaborated with notable individuals in his field, including Samuel A. Clark and Karl D. Normington. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Dennis McGarry is a distinguished inventor whose work in protein expression technology has paved the way for advancements in biotechnology. His contributions continue to influence research and therapeutic practices in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…